Skip to content

In the BioHarmony Drug Report Database

Verteporfin

Visudyne (verteporfin) is a small molecule pharmaceutical. Verteporfin was first approved as Visudyne on 2000-04-12. It is used to treat choroidal neovascularization in the USA. It has been approved in Europe to treat degenerative myopia and macular degeneration.
Trade Name Visudyne
Common Name Verteporfin
Indication choroidal neovascularization, degenerative myopia, macular degeneration
Drug Class Benzoporphyrin derivatives
Verteporfin
Get full access now